FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients-Reference-Cited by-同舟云学术

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients

Published:2017-05-08 Issue:1 Volume:36 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Tassi Renata A.,Todeschini Paola,Siegel Eric R.,Calza Stefano,Cappella Paolo,Ardighieri Laura,Cadei Moris,Bugatti Mattia,Romani Chiara,Bandiera Elisabetta,Zanotti Laura,Tassone Laura,Guarino Donatella,Santonocito Concetta,Capoluongo Ettore D.,Beltrame Luca,Erba Eugenio,Marchini Sergio,D’Incalci Maurizio,Donzelli Carla,Santin Alessandro D.,Pecorelli Sergio,Sartori Enrico,Bignotti Eliana,Odicino Franco,Ravaggi Antonella

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-017-0536-y.pdf

Reference64 articles.

1. Kurman RJ, Shih I. The Origin and Pathogenesis of Epithelial Ovarian Cancer- a Proposed Unifying Theory. Am J Surg Pathol. 2010;34:433–43.

2. DiSaia PJ, Creasman WT. Epithelial Ovarian Cancer. Clinical Gynecologic Oncology. St. Louis: Mosby Year Book, Inc; 2002. p. 185–206.

3. Prat J. New insights into ovarian cancer pathology. Ann Oncol. 2012;23(Suppl 10:x111-7):PMID: 22987944.

4. Köbel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 2008;5(12):e232.

5. Nik NN, Vang R, Shih IM, Kurman RJ. Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma. Annu Rev Pathol. 2014;9:27–45.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of Forkhead Box M1 and Anticancer Effects of FOXM1 Inhibition in Epithelioid Sarcoma;Laboratory Investigation;2024-08

2. FOXM1 transcriptional regulation;Biology of the Cell;2024-07-04

3. Generic orphan drug substitution: a critical analysis of global practices and Saudi Arabia’s perspective;Frontiers in Pharmacology;2024-04-18

4. PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti‐tumor effects;Molecular Oncology;2024-02-15

5. Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer;Expert Opinion on Therapeutic Targets;2024-01-23